Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04010266 · ClinicalTrials.gov registry record · NA
RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use
A NA study, sponsored by AppliedVR.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT04010266 is a NA study that has completed, run by AppliedVR. The registered enrollment target is 63 participants.
The verdict
NCT04010266, a NA study, has completed, sponsored by AppliedVR.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This is a single-center, prospective, randomized, controlled study of the appliedVR RelieVRx headset in subjects undergoing Total Knee Arthroplasty (TKA). This study will evaluate two primary endpoints - effectiveness of a single use of RelieVRx in the reduction of acute postoperative pain by 20%; and overall effectiveness of RelieVRx as an opioid-sparing intervention, where opioid consumption is reduced by at least 20% over a 90-day postoperative period in the interventional, standard of care (SOC) plus RelieVRx group compared to the control, SOC group.
Interventions
- DEVICE RelieVRx headset
- DRUG multi-modality pain management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04010266
The ClinicalTrials.gov registry entry for NCT04010266 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AppliedVR, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RelieVRx headset is the first listed.
NCT04010266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04010266 about?
NCT04010266 is a clinical study titled "RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use". This is a single-center, prospective, randomized, controlled study of the appliedVR RelieVRx headset in subjects undergoing Total Knee Arthroplasty (TKA). This study will evaluate two primary endpoints - effectiveness of a single use of RelieVRx in the reduction of acute postoperative pain by 20%; a...
What is the current status of trial NCT04010266?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2021-03-01. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04010266?
The interventions under investigation include: RelieVRx headset (DEVICE), multi-modality pain management (DRUG).
Who is sponsoring clinical trial NCT04010266?
This trial is sponsored by AppliedVR, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.